"Devices hurt by Obamacare, hospitals win: Kraws" (Replay and Transcript)

Posted by Laura Swartz

June 28, 2012 at 1:54 PM

This morning, Crystal Research CEO Jeff Kraws spoke with Reuters' Rhonda Schaffler about winners and losers of today's landmark Supreme Court ruling upholding Obamacare's individual mandate. Mr. Kraws discussed specific stocks to watch as well as sector trends for healthcare insurers, hospitals, pharma and biotech companies, medical records, medical schools, generics, and medical device companies, among others.

Read More

Topics: Crystal Research Associates, Newsworthy Events, Document Capture Technologies

CEO Jeff Kraws Weighs In on Obamacare Ruling: Stocks to Watch on Reuters Live Video

Posted by Laura Swartz

June 28, 2012 at 11:34 AM

Tune in live at 11:45 am this morning to Reuters Insider for an overview of the landmark healthcare ruling and its impact on your investments....recap to follow here.

Read More

Second Quarter FY2012 Financial Results and Business Update on LRAD Corp. (LRAD-NASDAQ)

Posted by Colleen Koski

June 21, 2012 at 10:12 AM

On June 21, 2012, Crystal Research issued a Quarterly Update on LRAD Corp. (LRAD-NASDAQ), a company developing and marketing acoustic hailing devices (AHD) that support the delivery and intelligibility of audio broadcasts over long ranges. The 12-page Update is available here.

Read More

Topics: LRAD

NEW RESEARCH: AtheroNova (AHRO-OTC) Works to Unclog Your Arteries

Posted by Laura Swartz

June 6, 2012 at 10:25 AM

New research available in our library at www.crystalra.com gives readers a complete description of the business of AtheroNova: its product development, milestones, competitive pressures, market opportunities, risks, and more. A 52-page report is available here, with future Quarterly Updates coming as AtheroNova advances this year.

Read More

Topics: AtheroNova, New Research, biotech

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic